Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near Tampa, FL

41 studies for Prostate Cancer are recruiting at 57 sites within 50 miles of Tampa, Florida, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near Tampa.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near Tampa

Showing 41 studies, nearest first.
  1. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Saint Joseph's Hospital/Children's Hospital-Tampa (Tampa, FL); Mease Countryside Hospital (Safety Harbor, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  2. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Moffitt Cancer Center - McKinley Campus (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  3. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    NCT04423211

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Moffitt Cancer Center - McKinley Campus (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  4. A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT07164443

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Moffitt Cancer Center (Tampa, FL); Bay Pines VA Healthcare System (Bay Pines, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. International Registry for Men With Advanced Prostate Cancer (IRONMAN)

    NCT03151629

    • Observational
    • Ages 21 years and older
    • Sex: Male

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores

    NCT03495427

    • Phase 2/3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: H. Lee Moffitt Cancer Center and Research Institute (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    NCT03972657

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt Cancer Center - McKinley Drive (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

    NCT04890613

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: H. Lee Moffitt Cancer Center and Research Institute Hospital (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #8 (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

    NCT05422911

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: James A. Haley Veterans Administration Hospital (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

    NCT05932862

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #16 (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

    NCT06193486

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Study of AZD0754 in Participants With Metastatic Prostate Cancer

    NCT06267729

    • Phase 1/2
    • Ages 18 to 130 years
    • Sex: Male

    Nearest site: Research Site (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT06533644

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

    NCT06801236

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Moffitt Cancer Center, Tampa (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

    NCT06879041

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Research Site (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

    NCT06952803

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Research Site (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

    NCT07005154

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: H. Lee Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study of LY4257496 in Participants With Cancer (OMNIRAY)

    NCT07114601

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Moffitt (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

    NCT07192614

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Research Site (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

    NCT07213674

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC

    NCT07476001

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

    NCT07594106

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: H. Lee Moffitt Cancer Center (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

    NCT06134232

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Florida Urology Partners (Riverview, FL); Advanced Urology Institute (Largo, FL)

    Distance to nearest recruiting site
    ~10 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  26. DESTINY-PANTUMOUR04

    NCT07124000

    • Observational
    • Ages 18 to 130 years
    • Sex: All

    Nearest site: Research Site (St. Petersburg, FL)

    Distance to nearest recruiting site
    ~18 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

    NCT07365995

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Florida Cancer Specialists- St. Petersburg (St. Petersburg, FL)

    Distance to nearest recruiting site
    ~18 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

    NCT07028853

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Advanced Urology Institute, LLC (Largo, FL)

    Distance to nearest recruiting site
    ~20 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

    NCT04787744

    • Phase 2/3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Bay Pines VA Healthcare System, Pay Pines, FL (Bay Pines, FL)

    Distance to nearest recruiting site
    ~22 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

    NCT05818683

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

    NCT06067841

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Florida Cancer Specialists Sarasota Drug Development Unit (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

    NCT06440005

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialist (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

    NCT06784193

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

    NCT06800313

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

    NCT06999187

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Dren Investigational Site (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

    NCT07082920

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

    NCT07189403

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT07225946

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

    NCT07319871

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    NCT07503808

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialists (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer

    NCT07746713

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Florida Cancer Specialists & Research Institute (Sarasota, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.